Witoon Jantararotai

Short-term outcomes of low-dose versus moderate-dose prednisolone in ocular myasthenia gravis: a retrospective cohort study

Abstract Background The optimal corticosteroid dose for treating ocular myasthenia gravis remains uncertain. Higher doses may increase the risk of adverse effects without providing additional clinical benefit. This study aimed to compare the effectiveness of low-dose versus moder...